The new Category III code, X579T, represents a significant milestone in the clinical and commercial advancement of QT Imaging's technology, recognizing the distinct clinical service enabled by its ...
QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company") a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging ...
Harmony Biosciences today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug ...
Dubai, UAE: ruya bank has partnered with specialist analytics and risk management consultancy 4most to design and implement its IFRS 9 Expected Credit Loss (ECL) framework, supporting the bank’s ...
The media are invited to a press activity on Government of Canada investments to strengthen the industrial and innovation capacity of organizations working in defence supply ...
There were seven items on the Red Bank consent agenda at the Feb. 17 commission meeting. On the request of several commissioners, three of those items were removed from the consent agenda, then ...
US FDA approves Harmony Biosciences’ pitolisant for the treatment of cataplexy in paediatric patients: Plymouth Meeting, Pennsylvania Thursday, February 19, 2026, 17:00 Hrs [IST ...
In Other Business: Square adds fresh syrup, Slurpees are nigh and Tractor Supply opens in Bridgeport
The syrup drought on the Decatur Square is officially over Dunn Rite Cafe, located at 112 W. Walnut St., opened Monday. The ...
Daily Voice on MSN
Maryland man in critical condition after morning police welfare check turns physical: AG
Maryland’s Independent Investigations Division is investigating a Baltimore County police use-of-force incident that left a ...
The Olympics are boosting spending in Italy, large-in-part thanks to Americans. In the U.K., Barclays is reportedly leading a meeting to seek support for an existing project. The meeting comes against ...
Stocktwits on MSN
Capricor or Sarepta: Two DMD stocks enter a high-stakes week – which one has more upside?
Capricor is preparing a February submission to the FDA for its DMD cell therapy Deramiocel, following a formal request for the full Phase 3 Hope-3 clinical study report. ・Koyfin expects Sarepta to ...
V Ten Capital Corp. (TSXV: VTEN.P) (“VTen” or the “Company”), announces, further to its news release dated September 29, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results